Article

Axial PsA: A distinct phenotype not to be confused with ankylosing spondylitis+psoriasis

• Read More

Article

Effect of alcohol consumption and smoking on PsA manifestations

• Read More

Article

Cognitive function significantly altered in PsA

• Read More

Article

Greater joint damage and higher disease activity increases risk for surgery in PsA

• Read More

Article

Understanding the bidirectional causal link between Crohn’s disease and PsA

• Read More

Article

Nailfold capillary abnormalities predict PsA in patients with psoriasis

• Read More

Article

Bimekizumab beneficial in PsA patients with inadequate response to or intolerance of TNFα inhibitors

• Read More

Article

BNT162b2 booster dose highly recommended for PsA patients on TNF inhibitors

• Read More

Article

Bimekizumab shows promise in PsA patients naive to bDMARD

• Read More

News

ITP: Biologic beat placebo, but few patients improved

Author:

Randy Dotinga

Exorbitant efgartigimod meets primary endpoint in only 21.8% of patients with chronic disease.

• Read More